[go: up one dir, main page]

WO2001019349A3 - Extended release formulation of etodolac - Google Patents

Extended release formulation of etodolac Download PDF

Info

Publication number
WO2001019349A3
WO2001019349A3 PCT/IB2000/001208 IB0001208W WO0119349A3 WO 2001019349 A3 WO2001019349 A3 WO 2001019349A3 IB 0001208 W IB0001208 W IB 0001208W WO 0119349 A3 WO0119349 A3 WO 0119349A3
Authority
WO
WIPO (PCT)
Prior art keywords
etodolac
release formulation
extended release
sustained release
once daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2000/001208
Other languages
French (fr)
Other versions
WO2001019349A2 (en
Inventor
Rajeev S Raghuvanshi
Ashok Rampal
Himadri Sen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN1210DE1999 external-priority patent/IN190974B/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to AU65892/00A priority Critical patent/AU6589200A/en
Publication of WO2001019349A2 publication Critical patent/WO2001019349A2/en
Publication of WO2001019349A3 publication Critical patent/WO2001019349A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A sustained release formulation of etodolac for once daily administration is described.
PCT/IB2000/001208 1999-09-10 2000-08-30 Extended release formulation of etodolac Ceased WO2001019349A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU65892/00A AU6589200A (en) 1999-09-10 2000-08-30 Extended release formulation of etodolac

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1210/DEL/99 1999-09-10
IN1210DE1999 IN190974B (en) 1999-09-10 1999-09-10
US09/648,949 US6586005B1 (en) 1999-09-10 2000-08-25 Extended release formulation of etodolac
US09/648,949 2000-08-25

Publications (2)

Publication Number Publication Date
WO2001019349A2 WO2001019349A2 (en) 2001-03-22
WO2001019349A3 true WO2001019349A3 (en) 2001-08-09

Family

ID=26324703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/001208 Ceased WO2001019349A2 (en) 1999-09-10 2000-08-30 Extended release formulation of etodolac

Country Status (3)

Country Link
CN (1) CN1227001C (en)
AU (1) AU6589200A (en)
WO (1) WO2001019349A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206505D0 (en) * 2002-03-19 2002-05-01 Euro Celtique Sa Pharmaceutical combination
US20060159751A1 (en) * 2002-04-11 2006-07-20 Mona Gogia Controlled release pharmaceutical compositions of carbidopa and levodopa
JP5220408B2 (en) * 2005-06-22 2013-06-26 武田薬品工業株式会社 Tablets containing poorly soluble active ingredients
KR101082774B1 (en) 2006-04-12 2011-11-11 닛뽕소다 가부시키가이샤 Method for producing extended release tablet
CN101259113B (en) * 2008-04-21 2013-02-13 沈阳药科大学 Etodolac osmotic pump type controlled-release preparation and preparation thereof
TR200908308A1 (en) 2010-01-18 2011-08-22 Turgut İlaçlari A.Ş. Sustained-release tablet formulation containing etodolac
CN102485215B (en) * 2010-12-03 2013-05-15 沈阳药科大学 Etodolac time-release pellet preparation and preparation method thereof
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
CN106727390A (en) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 A kind of etodolac sustained-release tablet and preparation method thereof
CN114699380A (en) * 2021-12-27 2022-07-05 南京联智医药科技有限公司 Etodolac tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748628A2 (en) * 1995-06-13 1996-12-18 American Home Products Corporation Oral formulations of S(+)-Etodolac
WO1999039698A1 (en) * 1998-02-04 1999-08-12 Duramed Pharmaceuticals, Inc. Sustained release formulation
WO2000009091A1 (en) * 1998-08-13 2000-02-24 Andrx Pharmaceuticals, Inc. Once daily analgesic tablet

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748628A2 (en) * 1995-06-13 1996-12-18 American Home Products Corporation Oral formulations of S(+)-Etodolac
WO1999039698A1 (en) * 1998-02-04 1999-08-12 Duramed Pharmaceuticals, Inc. Sustained release formulation
WO2000009091A1 (en) * 1998-08-13 2000-02-24 Andrx Pharmaceuticals, Inc. Once daily analgesic tablet

Also Published As

Publication number Publication date
CN1402631A (en) 2003-03-12
WO2001019349A2 (en) 2001-03-22
CN1227001C (en) 2005-11-16
AU6589200A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
AU2379501A (en) Transferring of a message
AU1325001A (en) Methods of making a superconductor
AU7432400A (en) Preparation of benzenediboronic acid via a disilylated aryl-intermediate
AU2001294196A1 (en) Nitrogenous five-membered ring compounds
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
AUPQ346399A0 (en) Stable idle procedure
IL147802A0 (en) Sustained release formulation of a peptide
AU2001297631A1 (en) Novel formulations of carvedilol
WO2001019349A3 (en) Extended release formulation of etodolac
AU5852300A (en) Heteroaromatic ring compounds
AU4456601A (en) Oxa(thia)zolidine derivative and anti-inflammatory drug
AU2001232348A1 (en) Sustained release preparations of physiologically active compound hardly solublein water and production process and use of the same
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AU1068101A (en) Transdermal administration of reboxetine
AU7487700A (en) Controlled release formulation for administration of an anti-inflammatory naphthalene derivative
AU2001267782A1 (en) Fast release bioadhesive microspheres for the sublingual administration of proximate principles
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU4338300A (en) A second mammalian tankyrase
AU7887400A (en) A slow release pharmaceutical composition
AU4301701A (en) A stable aqueous dispersion of nutrients
MY133635A (en) Extended release formulation of etodolac
AU5241200A (en) Retard formulation of amoxicillin for oral administration
AU4081300A (en) Centroid integration
AU7711800A (en) Novel uses of 2-bromopalmitate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 008143196

Country of ref document: CN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP